@skint that's a great idea that everyone needs to learn how to find and read scientific papers.
did you take your suggestion and do it before starting this thread? It certainly doesn't look like it.
the research report below is really quite explicit. I guess you didn't want to consider it,, preferring the safe emotional harbour of your conspiracy theory about doctors and medical science.
here's how you might do it. I googled "ivermectin and covid research" and started looking for a recent paper from a reputable source.
the following was published last month. It pretty much renders your posts on this thread as antivaxx onanism.
the following are the headlines and then the start of an article from an internet page marked phc.ox.ac.uk.
"New study shows ivermectin lacks meaningful benefits in COVID-19 treatment COVID-19 Clinical trials. March 13, 2024
"New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population."
(The article begins...)
"Despite early studies suggesting potential, the PRINCIPLE trial's findings – published in the Journal of Infection - indicate that ivermectin does not lead to clinically significant improvements in COVID-19 recovery times, hospital admissions, or mortality rates.
"While a modest two-day reduction in symptom duration, from 16 days to 14 days, was observed, this did not translate into clinically meaningful benefits or improvements in longer-term health outcomes.
"The PRINCIPLE trial, commissioned by the UK Department of Health and Social Care during the height of COVID-19 pandemic and funded in open competition and after peer-review through its rapid research response fund – via the National Institute for Health and Social Care – aimed to identify existing drugs that could be repurposed to treat COVID-19 patients in community settings.
"The trial focused on testing drugs that might speed recovery, reduce hospitalisations and deaths, and, later, on improve longer-term health outcomes compared to usual care, particularly for patients at highest risk of complications.
" Ivermectin, with antiparasitic and anti-inflammatory qualities, was initially considered a promising candidate based on early laboratory studies and small trials.
"However, this study finds that ultimately it is ineffective in altering the outcomes of COVID-19 infection in a largely vaccinated population. The researchers conclude that ivermectin should not be prescribed as a treatment for COVID-19 in such populations and recommend against conducting further trials on ivermectin for this purpose. "
